Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013 - Takeaways - MDSpire

Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013

  • By

  • Zafer Tandoğdu

  • Ricardo Bartoletti

  • Tomasso Cai

  • Mete Çek

  • Magnus Grabe

  • Ekaterina Kulchavenya

  • Bela Köves

  • Vandana Menon

  • Kurt Naber

  • Tamara Perepanova

  • Peter Tenke

  • Björn Wullt

  • Truls Erik Bjerklund Johansen

  • Florian Wagenlehner

  • December 11, 2015

  • 0 min

Share

  • 1

    Urosepsis is a significant cause of severe sepsis and septic shock, with high mortality rates of 28% and 41%, respectively.

  • 2

    Inadequate antibiotic coverage in urosepsis is a critical issue, necessitating better understanding of pathogen spectrum and resistance.

  • 3

    The GPIU study, conducted from 2003 to 2013, focused on infections in hospitalized urological patients, providing valuable data on urosepsis.

  • 4

    A total of 408 patients with microbiologically proven urosepsis were identified, representing 25.4% of HAUTIs in the study.

  • 5

    The study highlighted the need to reassess the appropriateness of using HAUTI data to represent urosepsis pathogen profiles and resistance.

Original Source(s)

Related Content